FDA Inspection
Alvogen, IncAlvogen, Inc – FDA Inspection, Jun 10, 2021
Record Details
This FDA Inspection record concerns Alvogen, Inc, with an inspection on June 10, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Alvogen, Inc
- Inspection Date
- June 10, 2021
- Product Type
- Drugs
View Company Profile
ID · e32de0f5-fece-4897-81fe-a850b7a7e46b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1144326
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- Failure to comply with REMS Implementation System
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Alvogen, Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| November 21, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 11, 2020 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 18, 2017 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 20, 2011 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Alvogen, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.